LifeSci Acquisition is one of Ibere Pharmaceuticals's top competitors. LifeSci Acquisition is a SPAC company that was founded in New York, New York in 2018. LifeSci Acquisition is in the Asset & Investment Management field.
CM Life Sciences is perceived as one of Ibere Pharmaceuticals's biggest rivals. CM Life Sciences was founded in 2020 in New York, New York. CM Life Sciences competes in the Investment Banking and Securities industry. CM Life Sciences generates $ less revenue than Ibere Pharmaceuticals.
BCLS Acquisition is a top competitor of Ibere Pharmaceuticals. BCLS Acquisition 's headquarters is in Boston, Massachusetts, and was founded in 2020. BCLS Acquisition competes in the Investment Banking and Securities field. BCLS Acquisition generates NaN% of Ibere Pharmaceuticals's revenue.